How to Buy Scpharmaceuticals Stock
Scpharmaceuticals Inc
scPharmaceuticals Inc. , a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products.
Scpharmaceuticals stock last closed at $2.56, down 0.39% from the previous day, and has decreased 43.98% in one year. It has overperformed other stocks in the Biotechnology industry by 0.34 percentage points. Scpharmaceuticals stock is currently +31.96% from its 52-week low of $1.94, and -54.69% from its 52-week high of $5.65.
At the moment, there are 50.28M SCPH shares outstanding. The market capitalization of SCPH is $128.73M. In the last 24 hours, 230,152 SCPH shares were traded.
How to Buy Scpharmaceuticals Stock
Wondering how to invest in Scpharmaceuticals stock? Here's how.
- Choose where to buy Scpharmaceuticals stock: You need to decide on an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you figure out where to buy Scpharmaceuticals stock.
- Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Put funds into your brokerage account: Pick your method of payment and add your details.
- Evaluate Scpharmaceuticals stock: The Scpharmaceuticals ticker symbol is SCPH. Is Scpharmaceuticals stock a good investment? Should you buy shares of SCPH? How do SCPH's underlying business fundamentals look? Do top analysts think Scpharmaceuticals is a good buy? Why has SCPH's stock price moved recently? (Hint: Our stock market research tools can help you figure out if SCPH is a good stock to buy).
- Execute your SCPH buy order: Decide if you will purchase SCPH shares at the current market price or use a limit order to buy SCPH shares at a specific price.
- Track your investment in SCPH: Create a watchlist to important updates regarding your new investment in Scpharmaceuticals shares.
Step 1: Choose where to buy Scpharmaceuticals stock
You need an online brokerage account in order to access the NASDAQ market and buy SCPH shares.
Our preferred brokerage: eToro
In our opinion, eToro is the best stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to world markets: From Technology to Industrials, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro offers a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've chosen the right brokerage, you'll need to fill out some personal information so you can buy SCPH stock today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to open your new brokerage account.
- Send your application by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you've finished signing up on the highest rated app to buy and sell stocks, your next step is to transfer the money for your investment:
Check out the video below if you need help depositing funds into your brokerage account.
Step 4: Evaluate Scpharmaceuticals stock
After you have decided on the best place to buy Scpharmaceuticals stock, it's important to evaluate their stock before you buy, so you truly understand the risk and opportunity.
Scpharmaceuticals stock data
Fundamentals of SCPH
WallStreetZen was built to help part-time investors perform more accurate fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on SCPH's stock page.
Is SCPH stock undervalued or overvalued?
You can use many financial metrics, analyses, models, and charts to gauge SCPH's true value.
Using relative valuations metrics:
- SCPH may be overvalued based on its P/B ratio of 9.66x, relative to Biotechnology industry P/B ratio of 4.04x
You can do additional valuation analysis on SCPH's stock here.
A quick look at SCPH Financials
Passed Health Checks:
- There are more short-term assets than long-term liabilities on the SCPH balance sheet.
- SCPH has cash burn of 70559000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the SCPH balance sheet.
Failed Health Checks:
- Total SCPH debt is higher than 5 years ago, relative to shareholder equity.
- SCPH profit margin has gone up by 1.69 percentage points in the past year, but the company is still unprofitable.
- SCPH has $75.66M in cash and short term investments. This is not enough to cover its annual cash burn of $70.56M.
- SCPH has a relatively high debt to equity ratio of 7.07.
Is Scpharmaceuticals stock a Buy, Hold, or Sell, according to analysts?
Out of 3 Equities analysts who track SCPH, the consensus analyst rating on SCPH is a Strong Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dig deeper into what analysts are saying on the Scpharmaceuticals stock forecast page.
Metrics for Advanced SCPH Traders
SCPH Performance Metrics
Last year, SCPH revenue was $36.33M. During the last one years, SCPH's revenue has increased by 167.28% per year. This was faster than the Biotechnology industry average of 44.31%.
You can research SCPH's earnings and revenue performance here.
Latest Insiders Trades at SCPH
Over the last 12 months, executives and large shareholders at SCPH have bought more shares than they have sold.
Rachael Nokes, CFO and Treasurer of SCPH, was the latest SCPH insider to sell. They sold $18,631.37 worth of SCPH stock on Jan 3, 2025.
Dig into more about who owns SCPH shares here.
Can I get consistent income from SCPH stock?
No, Scpharmaceuticals doesn't provide an income stream by paying out dividends.
What do other investors have to say about SCPH?
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Execute your SCPH buy order
You have two main options:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are generally fine. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a specific price, place a limit order.
Hit the Open Trade button and your broker will place the order.
If you need more info about investing in stocks on eToro, click the helpful video below:
Step 6: Track your investment in SCPH
Now that you own some SCPH shares, you'll want to keep up with your new investment.
Start a watchlist to get the latest updates about your SCPH stock.
SCPH Feed
How to Buy Stock in Scpharmaceuticals
To summarize, here are the 6 steps to buy Scpharmaceuticals stock:
- Choose where to buy Scpharmaceuticals stock
- Create a brokerage account
- Put funds into your brokerage account
- Evaluate Scpharmaceuticals stock
- Execute your SCPH buy order
- Track your investment in SCPH
If you are looking for a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to get updates on your new investment in Scpharmaceuticals, create a watchlist on WallStreetZen today.
Related "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.